BAIRD MEDICAL INVESTMENT HOL
BDMDNASDAQ🏆 #4880 by market capUS Equity
$0.25▼ $0.03 (−9.95%)
Pre-market · at closeTrack BDMD
Get earnings, price moves & breaking news on Telegram
24h▼ 9.9%
7d▼ 46.8%
14d▼ 57.0%
30d▼ 70.2%
ytd▼ 81.7%
1y▼ 82.6%
🏦Market Cap
$8M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $0.25 – $0.25
- 52-Week Range
- $0.23 – $3.70
- Volume (shares)
- 1,575
- Avg Volume (shares)
- —
- Shares Outstanding
- 32.0M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- $23M
- Last Q Revenue
- $10M
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- $-1.41
- Dividend Yield
- —
- Dilution (1yr)
- +32.1%
BAIRD MEDICAL INVESTMENT HOL
BDMDFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$23M▼ −39.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
83.8%▼ −5.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$26M▼ −266.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$1M▼ −84.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
28.9M▲ +32.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$19M▼ −$1M YoY
StockOtter · stockotter.spaceAbout BAIRD MEDICAL INVESTMENT HOL
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.
Latest News & Updates
News unavailable.